Clinical trials
Phase 1/2 Breast Neoplasms, Male trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| University of Washington | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| City of Hope Medical Center | 1 |
| Innocrin Pharmaceutical | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| NYU Langone Health | 1 |
| Northwestern University | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 29 |
| Breast Neoplasms, Male | 29 |
| Triple Negative Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Brain Neoplasms | 2 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Inflammatory Breast Neoplasms | 2 |
Trials
Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.